K
Karius
kariusdx.comHeadquarters
United States
Valuation
$983M
Total Funding
$329M
Investors
General Catalyst, Khosla Ventures, Lightspeed Venture Partners
Description
Innovative infectious disease diagnostics powered by microbial DNA and NGS—enabling earlier, broader, and more precise infection detection.